Invesco S&P International Developed Momentum ETF (IDMO) Price, Holdings & Fund Facts

$62.87

+$0.71 · +1.14%

Aug 21, 2026, 09:30 – Aug 21, 2026, 15:59Eastern TimeET

Low: $62.725
High: $63.13

Regular session · ET · Market data may be delayed.

About this ETF

The Fund seeks investment result that correspond to the performance of the S&P World Ex-U.S. Momentum Index. It will invest at least 90% of its assets in securities that comprise the Index which is designed to measure the performance of large- and mid-cap securities in developed markets excluding US and South Korea.

Asset class: Equity
Issuer: Invesco
Domicile: US
Inception date: Feb 24, 2012
Holdings: 192
ISIN: US46138E2220

Key fund statistics

Fund assets

4.33B USD

Expense ratio

0.25%

NAV

$62.78

Average volume

370.47K

Volume

561.39K

Day range

$62.675 – $63.09

52-week range

$51.91 – $63.88

Previous close

$62.16

Price change

Performance

1 day

+1.16%

1 month

+5.77%

3 months

+5.24%

Year to date

+13.15%

1 year

+18.96%

3 years

+87.81%

5 years

+77.93%

Price changes exclude distributions, fees, taxes, and investor-specific cash flows.

Portfolio

Top holdings

RankHoldingSymbolWeight

01

HSBC Holdings PLCHSBA.LHSBA.L4.68%

02

Banco Santander SASAN.MCSAN.MC4.18%

03

Toronto-Dominion Bank/TheTDTD3.94%

04

Banco Bilbao Vizcaya Argentaria SABBVA.MCBBVA.MC2.94%

05

Rolls-Royce Holdings PLCRR.LRR.L2.64%

06

Advantest Corp6857.T6857.T2.52%

07

Siemens Energy AGENR.DEENR.DE2.04%

08

Iberdrola SAIBE.MCIBE.MC2.03%

09

UniCredit SpAUCG.MIUCG.MI1.92%

10

Barrick Mining CorpBB1.67%

11

Bank of Nova Scotia/TheBNSBNS1.66%

12

Mitsubishi Corp8058.T8058.T1.59%

13

Kioxia Holdings Corp285A.T285A.T1.54%

14

Canadian Imperial Bank of CommerceCMCM1.52%

15

Lloyds Banking Group PLCLLOY.LLLOY.L1.50%

Holdings data updated Aug 23, 2026.

Portfolio composition

Exposure

Sector exposure

Top 10

Financial Services47.08%

Industrials20.20%

Basic Materials8.94%

Utilities7.88%

Technology5.43%

Consumer Defensive2.53%

Communication Services2.01%

Real Estate1.76%

Energy1.63%

Healthcare1.30%

Country exposure

Top 10

Japan20.89%

Canada16.50%

United Kingdom15.14%

Spain11.30%

Germany7.13%

Italy5.91%

Israel4.14%

France3.42%

Hong Kong3.06%

Singapore2.40%

Fund income

Distributions

Ex-dividend dateRecord datePayment dateAmount

Jun 22, 2026

Quarterly

Jun 22, 2026

Jun 26, 2026

$0.517

Quarterly

Mar 23, 2026

Quarterly

Mar 23, 2026

Mar 27, 2026

$0.2657

Quarterly

Dec 22, 2025

Quarterly

Dec 22, 2025

Dec 26, 2025

$1.2357

Quarterly

Sep 22, 2025

Quarterly

Sep 22, 2025

Sep 26, 2025

$0.1735

Quarterly

Jun 23, 2025

Quarterly

Jun 23, 2025

Jun 27, 2025

$0.4298

Quarterly

Mar 24, 2025

Quarterly

Mar 24, 2025

Mar 28, 2025

$0.2239

Quarterly

Dec 23, 2024

Quarterly

Dec 23, 2024

Dec 27, 2024

$0.0965

Quarterly

Sep 23, 2024

Quarterly

Sep 23, 2024

Sep 27, 2024

$0.2767

Quarterly

Jun 24, 2024

Quarterly

Jun 24, 2024

Jun 28, 2024

$0.2335

Quarterly

Mar 18, 2024

Quarterly

Mar 19, 2024

Mar 22, 2024

$0.3029

Quarterly

Latest coverage

IDMO news

businesswire.comJun 15, 2026

Cellares Grows Series D to $327 Million with $50 Million Prime Radiant Partners Investment

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Cellares, the first Integrated Development and Manufacturing Organization (IDMO), today announced that Prime Radiant Fund SLP SICAV-RAIF, a fund advised by Prime Radiant…

Read source

gurufocus.comJun 3, 2026

Cellares and TScan Therapeutics Announce Agreement to Evaluate Automated Manufacturing of TSC-101 for Patients with Hematologic Malignancies

Cellares, the first Integrated Development and Manufacturing Organization (IDMO), and TScan Therapeutics, Inc. (Nasdaq: TCRX), a clinical-stage biotechnology c

Read source

seekingalpha.comJun 1, 2026

IDMO: A Buy For Investors Seeking Momentum Abroad

The Invesco S&P Intl Developed Momentum ETF (IDMO) offers disciplined, rules-based international momentum exposure, diverging from traditional market-cap-weighted ETFs. I rate IDMO a BUY for investors seeking dedicated…

Read source

seekingalpha.comJun 1, 2026

IDMO Vs. EFA: Momentum Investing Shows Great Track Record Thus A Strong Buy

I compare iShares MSCI EAFE ETF and Invesco S&P Intl Developed Momentum ETF for international developed market exposure. EFA tracks the MSCI EAFE Index, offering broad diversification across 21 developed markets, with…

Read source

seekingalpha.comMay 29, 2026

IDMO: Good Fundamentals And Even Better Performance

Invesco S&P Intl Developed Momentum ETF earns a 'buy' rating for its strong fundamentals and long-term risk-adjusted outperformance versus peers. IDMO trades at an attractive 15.81x trailing earnings, offering compelling…

Read source

More funds

Explore more ETFs

Browse all ETFs

Vanguard Morningstar Total Stock Market ETF

VTI

$378.24

+0.44%

Vanguard S&P 500 ETF

VOO

$703.71

+0.39%

iShares Core S&P 500 ETF

IVV

$769.31

+0.39%

State Street SPDR S&P 500 ETF

SPY

$765.72

+0.41%

Vanguard Morningstar Growth ETF

VUG

$87.50

+0.38%

Vanguard FTSE Developed Markets ETF

VEA

$73.42

+0.80%

Loading ETF research

Invesco S&P International Developed Momentum ETF

About this ETF

Key fund statistics

Performance

Top holdings

Exposure

Sector exposure

Country exposure

Distributions

IDMO news

Cellares Grows Series D to $327 Million with $50 Million Prime Radiant Partners Investment

Cellares and TScan Therapeutics Announce Agreement to Evaluate Automated Manufacturing of TSC-101 for Patients with Hematologic Malignancies

IDMO: A Buy For Investors Seeking Momentum Abroad

IDMO Vs. EFA: Momentum Investing Shows Great Track Record Thus A Strong Buy

IDMO: Good Fundamentals And Even Better Performance

Explore more ETFs

Continue researching IDMO

Loading ETF research

Invesco S&P International Developed Momentum ETF

IDMO ETF overview

About this ETF

Key fund statistics

Performance

Top holdings

Exposure

Sector exposure

Country exposure

Distributions

IDMO news

Cellares Grows Series D to $327 Million with $50 Million Prime Radiant Partners Investment

Cellares and TScan Therapeutics Announce Agreement to Evaluate Automated Manufacturing of TSC-101 for Patients with Hematologic Malignancies

IDMO: A Buy For Investors Seeking Momentum Abroad

IDMO Vs. EFA: Momentum Investing Shows Great Track Record Thus A Strong Buy

IDMO: Good Fundamentals And Even Better Performance

Explore more ETFs

Continue researching IDMO